220 related articles for article (PubMed ID: 27500785)
1. Pathways of protein and lipid receptor-mediated transcytosis in drug delivery.
Thuenauer R; Müller SK; Römer W
Expert Opin Drug Deliv; 2017 Mar; 14(3):341-351. PubMed ID: 27500785
[TBL] [Abstract][Full Text] [Related]
2. Gb3-binding lectins as potential carriers for transcellular drug delivery.
Müller SK; Wilhelm I; Schubert T; Zittlau K; Imberty A; Madl J; Eierhoff T; Thuenauer R; Römer W
Expert Opin Drug Deliv; 2017 Feb; 14(2):141-153. PubMed ID: 27935765
[TBL] [Abstract][Full Text] [Related]
3. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery.
Widera A; Norouziyan F; Shen WC
Adv Drug Deliv Rev; 2003 Nov; 55(11):1439-66. PubMed ID: 14597140
[TBL] [Abstract][Full Text] [Related]
5. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
6. Transcytosis of macromolecules at the blood-brain barrier.
Preston JE; Joan Abbott N; Begley DJ
Adv Pharmacol; 2014; 71():147-63. PubMed ID: 25307216
[TBL] [Abstract][Full Text] [Related]
7. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
8. Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier.
Holst MR; de Wit NM; Ozgür B; Brachner A; Hyldig K; Appelt-Menzel A; Sleven H; Cader Z; de Vries HE; Neuhaus W; Jensen A; Brodin B; Nielsen MS
Fluids Barriers CNS; 2023 Nov; 20(1):82. PubMed ID: 37932749
[TBL] [Abstract][Full Text] [Related]
9. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
10. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
11. Transcellular routes of blood-brain barrier disruption.
Erickson MA; Banks WA
Exp Biol Med (Maywood); 2022 May; 247(9):788-796. PubMed ID: 35243912
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
13. Physiological blood-brain transport is impaired with age by a shift in transcytosis.
Yang AC; Stevens MY; Chen MB; Lee DP; Stähli D; Gate D; Contrepois K; Chen W; Iram T; Zhang L; Vest RT; Chaney A; Lehallier B; Olsson N; du Bois H; Hsieh R; Cropper HC; Berdnik D; Li L; Wang EY; Traber GM; Bertozzi CR; Luo J; Snyder MP; Elias JE; Quake SR; James ML; Wyss-Coray T
Nature; 2020 Jul; 583(7816):425-430. PubMed ID: 32612231
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery to brain via the blood-brain barrier.
Scherrmann JM
Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers.
Hersom M; Helms HC; Pretzer N; Goldeman C; Jensen AI; Severin G; Nielsen MS; Holm R; Brodin B
Mol Cell Neurosci; 2016 Oct; 76():59-67. PubMed ID: 27567687
[TBL] [Abstract][Full Text] [Related]
16. Intracellular transport and regulation of transcytosis across the blood-brain barrier.
Villaseñor R; Lampe J; Schwaninger M; Collin L
Cell Mol Life Sci; 2019 Mar; 76(6):1081-1092. PubMed ID: 30523362
[TBL] [Abstract][Full Text] [Related]
17. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
18. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
19. Targeting blood-brain-barrier transcytosis - perspectives for drug delivery.
Mäger I; Meyer AH; Li J; Lenter M; Hildebrandt T; Leparc G; Wood MJA
Neuropharmacology; 2017 Jul; 120():4-7. PubMed ID: 27561970
[TBL] [Abstract][Full Text] [Related]
20. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.
Jafari B; Pourseif MM; Barar J; Rafi MA; Omidi Y
Expert Opin Drug Deliv; 2019 Jun; 16(6):583-605. PubMed ID: 31107110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
